1. Budhathoki-Uprety, J.; Langenbacher, R. E.; Jena, P. V.; Roxbury, D.; Heller, D.A.; “A Carbon Nanotube Optical Sensor Reports Nuclear Entry via a Noncanonical Pathway”, ACS. Nano. 2017, 11,3875–3882.
2. Budhathoki-Uprety, J.; Harvey, J.D.; Isaac, E.; Williams, R.M.; Galassi, T.V.; Langenbacher, R. E.; Jena, P. V.; Heller, D.A.; “Polymer Cloaking Modulates the Carbon Nanotube Protein Corona and Delivery into Cancer Cells”, J. Mater. Chem. B., 2017, 5, 6637–6644.
3. Jena, P. V.; Roxbury, D.; Galassi, T. V.; Akkari, L.; Horoszko, C. P.; Iaea, D. B.; Budhathoki-Uprety, J.; Pipalia, N. H.; Haka, A. S.; Harvey, J.D.;Mittal, J.; Maxfield, F. R.; Joyce, J. A.; Heller, D.A.; “A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux”, ACS Nano 2017, DOI: 10.1021/acsnano.7b04743
4. Kossatz S, Weber WA, Reiner T. Commentary: Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Molecular Imaging, 2017, Jan-Dec; 16:1536012117723786. PMID: 28856922.
5. Büchel GE, Kossatz S, Sadique A, Rapta P, Zalibera M, Bucinsky L, Komorovsky S, Telser J, Eppinger J, Reiner T, Arion VB. cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339. Dalton Transactions, 2017, Sep 12;46(35):11925-11941. PMID: 28850133.
6. Tang J, Salloum D, Carney B, Brand C, Kossatz S, Sadique A, Weber WA, Wendel HG, Reiner T. A Targeted PET Imaging Strategy to Differentiate Malignant from Inflamed Lymph Nodes in Diffuse Large B-Cell Lymphoma. Proceedings of the National Academy of Sciences, 2017, 201705013. PMID: 28827325.
7. Ghosh SC, Hernandez Vargas S, Rodriguez M, Kossatz S, Voss J, Carmon KS, Reiner T, Schonbrunn A, Azhdarinia A. Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting. ACS Medicinal Chemistry Letters, 2017, Jun 6;8(7):720-725. PMID: 28740605.
8. Carney B*, Kossatz S*, Reiner T. Molecular Imaging of PARP. Journal of Nuclear Medicine, 2017, Jul 1;58(7):1025-30. PMID: 28473593. *contributed equally
9. Kossatz S, Carney B, Schweitzer ME, Carlucci G, Miloushev V, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA, Souweidane MM, Reiner T. Biomarker based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models. Cancer Research, 2017, 77.8: 2112-2123. PMID: 28108511.
10. Büchel, G. E., Carney, B., Tang, J., Zeglis, B. M., Eppinger, J. & Reiner, T. A Novel Technique for Generating and Observing Chemiluminescence in a Biological Setting. JoVE (2017)
11. Carlucci, G., Carney, B., Sadique, A., Vansteene, A., Tang, J. & Reiner, T. Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer. Nucl Med Biol.
12. Büchel, G. E., Carney, B., Shaffer, T. M., Tang, J., Austin, C., Arora, M., Zeglis, B. M., Grimm, J., Eppinger, J. & Reiner, T. Near-Infrared Intraoperative Chemiluminescence Imaging. ChemMedChem.
13. Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis. J Nucl Med, 2016
14. Sharma SK, Nemieboka B, Sala E, Lewis JS, Zeglis BM. Molecular Imaging of Ovarian Cancer. Journal of Nuclear Medicine. 2016;57:827-833. Published online: April 28, 2016. Doi: 10.2967/jnumed.115.172023.
15. Tee SS, DiGialleonardo V, Eskandari R, Jeong S, Granlund KL, Miloushev V, Poot AJ, Truong S, Alvarez JA, Aldeborgh HN, Keshari KR. Sampling Hyperpolarized Molecules Utilizing a 1 Tesla Permanent Magnetic Field. Sci Rep. 2016.
16. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate. Brendon E. Cook, Pierre Adumeau, Rosemery Membreno, Kathryn E. Carnazza, Christian Brand, Thomas Reiner, Brian J. Agnew, Jason S. Lewis, and Brian M. Zeglis. Bioconjugate Chemistry 2016 27 (8), 1789-1795
17. Chen F, Ma K, Zhang L, Madajewski B, Zanzonico P, Sequeira S, et al. Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies. Chemistry of Materials. 2017
18. Kelly E. Henry, Megan M. Dacek, Thomas R. Dilling, Jonathan D. Caen, Michael J. Evans, Jason S. Lewis. Interrogation of MYC and ERK Signaling with 89Zr-Transferrin PET in Human Pancreatic Ductal Adenocarcinoma. Under Review.
19. Kelly E. Henry, Gary A. Ulaner, Jason S. Lewis. Clinical Benefit of HER2 and HER3 Imaging. Under Review.
20. Kelly E. Henry, Thomas R. Dilling, Dalya Abdel-Atti, Kimberly J. Edwards, Michael J. Evans, Jason S. Lewis. Non-invasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared to 18F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer. Journal of Nuclear Medicine 2017, Ahead of Print. doi: 10.2967/jnumed.117.192286.
21. Kelly E. Henry, Gary A. Ulaner, Jason S. Lewis. HER2-Targeted PET/SPECT Imaging of Breast Cancer: Non-Invasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis. PET Clinics 2017,12(3):269-288.